Though with similar effects as some pre-existing drugs (semaglutide, liraglutide, exenatide, etc.) targeting diabetes and obesity, tirzepatide is considered a first-in-class medication for demonstrating action on both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
1 Recommended Topics Recommended Topics
Retatrutide vs Mounjaro: The Future of Weight Management
Previous weight loss attempts: If lifestyle changes or other medications havent produced long-term results, GLP-1 injections may be an option
Life stress, the kindling hypothesis, and the recurrence of depression: considerations from a life stress perspective
Comparing Elevate Health to Other Telehealth GLP-1 Platforms The telehealth GLP-1 space grew crowded through 2024 and into 2025, with multiple platforms competing on price, medication options, and service features